Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 358713, 8 pages
http://dx.doi.org/10.1155/2015/358713
Review Article

Role of Oxidative RNA Damage in Chronic-Degenerative Diseases

Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, 47921 Rimini, Italy

Received 8 December 2014; Revised 20 April 2015; Accepted 21 April 2015

Academic Editor: Mark J. Crabtree

Copyright © 2015 Carmela Fimognari. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Miller and B. E. Britigan, “Role of oxidants in microbial pathophysiology,” Clinical Microbiology Reviews, vol. 10, no. 1, pp. 1–18, 1997. View at Google Scholar · View at Scopus
  2. P. Pacher, J. S. Beckman, and L. Liaudet, “Nitric oxide and peroxynitrite in health and disease,” Physiological Reviews, vol. 87, no. 1, pp. 315–424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. S. Cooke, M. D. Evans, M. Dizdaroglu, and J. Lunec, “Oxidative DNA damage: mechanisms, mutation, and disease,” The FASEB Journal, vol. 17, no. 10, pp. 1195–1214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. Q. Kong and C.-L. G. Lin, “Oxidative damage to RNA: mechanisms, consequences, and diseases,” Cellular and Molecular Life Sciences, vol. 67, no. 11, pp. 1817–1829, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Delaney, D. A. Jarem, C. B. Volle, and C. J. Yennie, “Chemical and biological consequences of oxidatively damaged guanine in DNA,” Free Radical Research, vol. 46, no. 4, pp. 420–441, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Menon, “Oxidative stress damage as a detrimental factor in preterm birth pathology,” Frontiers in Immunology, vol. 5, article 567, 2014. View at Publisher · View at Google Scholar
  7. J. Cadet, J. R. Wagner, V. Shafirovich, and N. E. Geacintov, “One-electron oxidation reactions of purine and pyrimidine bases in cellular DNA,” International Journal of Radiation Biology, vol. 90, no. 6, pp. 423–432, 2014. View at Publisher · View at Google Scholar
  8. A. M. Fleming, O. R. Alshykhly, J. Zhu, J. G. Muller, and C. J. Burrows, “Rates of chemical cleavage of DNA and RNA oligomers containing guanine oxidation products,” Chemical Research in Toxicology, 2015. View at Publisher · View at Google Scholar
  9. E. Gajewski, G. Rao, Z. Nackerdien, and M. Dizdaroglu, “Modification of DNA bases in mammalian chromatin by radiation-generated free radicals,” Biochemistry, vol. 29, no. 34, pp. 7876–7882, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. E. S. Henle and S. Linn, “Formation, prevention, and repair of DNA damage by iron/hydrogen peroxide,” The Journal of Biological Chemistry, vol. 272, no. 31, pp. 19095–19098, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. E. J. Wurtmann and S. L. Wolin, “RNA under attack: cellular handling of RNA damage,” Critical Reviews in Biochemistry and Molecular Biology, vol. 44, no. 1, pp. 34–49, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. W. L. Neeley and J. M. Essigmann, “Mechanisms of formation, genotoxicity, and mutation of guanine oxidation products,” Chemical Research in Toxicology, vol. 19, no. 4, pp. 491–505, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Rhee, M. R. Valentine, and J. Termini, “Oxidative base damage in RNA detected by reverse transcriptase,” Nucleic Acids Research, vol. 23, no. 16, pp. 3275–3282, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Shan and C.-L. G. Lin, “Quantification of oxidized RNAs in Alzheimer's disease,” Neurobiology of Aging, vol. 27, no. 5, pp. 657–662, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. Q. Ding, W. R. Markesbery, Q. Chen, F. Li, and J. N. Keller, “Ribosome dysfunction is an early event in Alzheimer's disease,” Journal of Neuroscience, vol. 25, no. 40, pp. 9171–9175, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Hofer, C. Badouard, E. Bajak, J.-L. Ravanat, Å. Mattsson, and I. A. Cotgreave, “Hydrogen peroxide causes greater oxidation in cellular RNA than in DNA,” Biological Chemistry, vol. 386, no. 4, pp. 333–337, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Wu and Z. Li, “Human polynucleotide phosphorylase reduces oxidative RNA damage and protects HeLa cell against oxidative stress,” Biochemical and Biophysical Research Communications, vol. 372, no. 2, pp. 288–292, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Nunomura, G. Perry, M. A. Pappolla et al., “RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease,” Journal of Neuroscience, vol. 19, no. 6, pp. 1959–1964, 1999. View at Google Scholar · View at Scopus
  19. Z. Shen, W. Wu, and S. L. Hazen, “Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical,” Biochemistry, vol. 39, no. 18, pp. 5474–5482, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. E. S. Fiala, C. C. Conaway, and J. E. Mathis, “Oxidative DNA and RNA damage in the livers of Sprague-Dawley rats treated with the hepatocarcinogen 2-nitropropane,” Cancer Research, vol. 49, no. 20, pp. 5518–5522, 1989. View at Google Scholar · View at Scopus
  21. T. Hofer, A. Y. Seo, M. Prudencio, and C. Leeuwenburgh, “A method to determine RNA and DNA oxidation simultaneously by HPLC-ECD: greater RNA than DNA oxidation in rat liver after doxorubicin administration,” Biological Chemistry, vol. 387, no. 1, pp. 103–111, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Honda, M. A. Smithi, X. Zhu et al., “Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron,” The Journal of Biological Chemistry, vol. 280, no. 22, pp. 20978–20986, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Hofer, E. Marzetti, J. Xu et al., “Increased iron content and RNA oxidative damage in skeletal muscle with aging and disuse atrophy,” Experimental Gerontology, vol. 43, no. 6, pp. 563–570, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Kajitani, H. Yamaguchi, Y. Dan, M. Furuichi, D. Kang, and Y. Nakabeppu, “MTH1, an oxidized purine nucleoside triphosphatase, suppresses the accumulation of oxidative damage of nucleic acids in the hippocampal microglia during kainate-induced excitotoxicity,” Journal of Neuroscience, vol. 26, no. 6, pp. 1688–1698, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Hayakawa, M. Kuwano, and M. Sekiguchi, “Specific binding of 8-oxoguanine-containing RNA to polynucleotide phosphorylase protein,” Biochemistry, vol. 40, no. 33, pp. 9977–9982, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Hayakawa and M. Sekiguchi, “Human polynucleotide phosphorylase protein in response to oxidative stress,” Biochemistry, vol. 45, no. 21, pp. 6749–6755, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Hayakawa, A. Hofer, L. Thelander et al., “Metabolic fate of oxidized guanine ribonucleotides in mammalian cells,” Biochemistry, vol. 38, no. 12, pp. 3610–3614, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Ishibashi, H. Hayakawa, R. Ito, M. Miyazawa, Y. Yamagata, and M. Sekiguchi, “Mammalian enzymes for preventing transcriptional errors caused by oxidative damage,” Nucleic Acids Research, vol. 33, no. 12, pp. 3779–3784, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Brégeon and A. Sarasin, “Hypothetical role of RNA damage avoidance in preventing human disease,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 577, no. 1-2, pp. 293–302, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Hayakawa, T. Uchiumi, T. Fukuda et al., “Binding capacity of human YB-1 protein for RNA containing 8-oxoguanine,” Biochemistry, vol. 41, no. 42, pp. 12739–12744, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Li and M. P. Deutscher, “Exoribonucleases and endoribonucleases,” in EcoSal—Escherichia coli and Salmonella: Cellular and Molecular Biology, R. Curtiss III, Ed., chapter 4.6.3, ASM Press, Washington, DC, USA, 2004. View at Google Scholar
  32. M. A. Skabkin, V. Evdokimova, A. A. M. Thomas, and L. P. Ovchinnikov, “The major messenger ribonucleoprotein particle protein p50 (YB-1) promotes nucleic acid strand annealing,” The Journal of Biological Chemistry, vol. 276, no. 48, pp. 44841–44847, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. M. P. Deutscher, “Degradation of RNA in bacteria: comparison of mRNA and stable RNA,” Nucleic Acids Research, vol. 34, no. 2, pp. 659–666, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Hegde, M. Wang, and W. A. Deutsch, “Characterization of human ribosomal protein S3 binding to 7,8-dihydro-8-oxoguanine and abasic sites by surface plasmon resonance,” DNA Repair, vol. 3, no. 2, pp. 121–126, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Martinet, G. R. Y. de Meyer, A. G. Herman, and M. M. Kockx, “Reactive oxygen species induce RNA damage in human atherosclerosis,” European Journal of Clinical Investigation, vol. 34, no. 5, pp. 323–327, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. Q. Ding, W. R. Markesbery, V. Cecarini, and J. N. Keller, “Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease,” Neurochemical Research, vol. 31, no. 5, pp. 705–710, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. D. M. Thompson, C. Lu, P. J. Green, and R. Parker, “tRNA cleavage is a conserved response to oxidative stress in eukaryotes,” RNA, vol. 14, no. 10, pp. 2095–2103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Nunomura, P. I. Moreira, A. Takeda, M. A. Smith, and G. Perry, “Oxidative RNA damage and neurodegeneration,” Current Medicinal Chemistry, vol. 14, no. 28, pp. 2968–2975, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Nunomura, T. Tamaoki, N. Motohashi et al., “The earliest stage of cognitive impairment in transition from normal aging to alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons,” Journal of Neuropathology and Experimental Neurology, vol. 71, no. 3, pp. 233–241, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Zhang, G. Perry, M. A. Smith et al., “Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons,” The American Journal of Pathology, vol. 154, no. 5, pp. 1423–1429, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Nunomura, G. Perry, G. Aliev et al., “Oxidative damage is the earliest event in Alzheimer disease,” Journal of Neuropathology and Experimental Neurology, vol. 60, no. 8, pp. 759–767, 2001. View at Google Scholar · View at Scopus
  42. Q. Ding, H. Zhu, B. Zhang, A. Soriano, R. Burns, and W. R. Markesbery, “Increased 5S rRNA oxidation in Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 29, no. 1, pp. 201–209, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Isobe, T. Abe, and Y. Terayama, “Homocysteine may contribute to pathogenesis of RNA damage in brains with Alzheimer's disease,” Neurodegenerative Diseases, vol. 6, no. 5-6, pp. 252–257, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Kikuchi, A. Takeda, H. Onodera et al., “Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy,” Neurobiology of Disease, vol. 9, no. 2, pp. 244–248, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Nunomura, T. Hofer, P. I. Moreira, R. J. Castellani, M. A. Smith, and G. Perry, “RNA oxidation in Alzheimer disease and related neurodegenerative disorders,” Acta Neuropathologica, vol. 118, no. 1, pp. 151–166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. R. B. Petersen, S. L. Siedlak, H.-G. Lee et al., “Redox metals and oxidative abnormalities in human prion diseases,” Acta Neuropathologica, vol. 110, no. 3, pp. 232–238, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Hayashi, N. Arai, J. Satoh et al., “Neurodegenerative mechanisms in subacute sclerosing panencephalitis,” Journal of Child Neurology, vol. 17, no. 10, pp. 725–730, 2002. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Chang, Q. Kong, X. Shan et al., “Messenger RNA oxidation occurs early in disease pathogenesis and promotes motor neuron degeneration in ALS,” PLoS ONE, vol. 3, Article ID e2849, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Nunomura, R. J. Castellani, X. Zhu, P. I. Moreira, G. Perry, and M. A. Smith, “Involvement of oxidative stress in Alzheimer disease,” Journal of Neuropathology & Experimental Neurology, vol. 65, no. 7, pp. 631–641, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. X. Shan, H. Tashiro, and C.-L. G. Lin, “The identification and characterization of oxidized RNAs in Alzheimer's disease,” The Journal of Neuroscience, vol. 23, no. 12, pp. 4913–4921, 2003. View at Google Scholar · View at Scopus
  51. A. Nunomura, P. I. Moreira, R. J. Castellani et al., “Oxidative damage to RNA in aging and neurodegenerative disorders,” Neurotoxicity Research, vol. 22, no. 3, pp. 231–248, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. X. Shan, Y. Chang, and C.-L. G. Lin, “Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression,” The FASEB Journal, vol. 21, no. 11, pp. 2753–2764, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Tanaka, P. B. Chock, and E. R. Stadtman, “Oxidized messenger RNA induces translation errors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 1, pp. 66–71, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Beghi, R. Savica, E. Beghi, A. Nobili, and L. Garattini, “Utilization and costs of antiepileptic drugs in the elderly: still an unsolved issue,” Drugs & Aging, vol. 26, no. 2, pp. 157–168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Vercueil, “Epilepsy and neurodegenerative diseases in adults: a clinical review,” Epileptic Disorders, vol. 8, no. 1, pp. S44–S54, 2006. View at Google Scholar · View at Scopus
  56. E. Garcion, B. Wallace, L. Pelletier, and D. Wion, “RNA mutagenesis and sporadic prion diseases,” Journal of Theoretical Biology, vol. 230, no. 2, pp. 271–274, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. P. H. Frederikse, J. S. Zigler Jr., P. N. Farnsworth, and D. A. Carper, “Prion protein expression in mammalian lenses,” Current Eye Research, vol. 20, no. 2, pp. 137–143, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Capellari, S. I. A. Zaidi, C. B. Urig, G. Perry, M. A. Smith, and R. B. Petersen, “Prion protein glycosylation is sensitive to redox change,” The Journal of Biological Chemistry, vol. 274, pp. 34846–34850, 1999. View at Publisher · View at Google Scholar
  59. W. Martinet, G. R. Y. De Meyer, A. G. Herman, and M. M. Kockx, “RNA damage in human atherosclerosis: pathophysiological significance and implications for gene expression studies,” RNA Biology, vol. 2, pp. 4–7, 2005. View at Google Scholar · View at Scopus
  60. D. J. Smith and R. C. Anderson, “Toxicity and metabolism of nitroalkanes and substituted nitroalkanes,” Journal of Agricultural and Food Chemistry, vol. 61, no. 4, pp. 763–779, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. C. C. Conaway, G. Nie, N. S. Hussain, and E. S. Fiala, “Comparison of oxidative damage to rat liver DNA and RNA by primary nitroalkanes, secondary nitroalkanes, cyclopentanone oxime, and related compounds,” Cancer Research, vol. 51, no. 12, pp. 3143–3147, 1991. View at Google Scholar · View at Scopus
  62. L. Fishbein, “Carcinogenicity and mutagenicity of solvents. I. Glycidyl ethers, dioxane, nitroalkanes, dimethylformamide and allyl derivatives,” Science of the Total Environment, vol. 17, no. 2, pp. 97–110, 1981. View at Publisher · View at Google Scholar · View at Scopus
  63. N. Guo, C. C. Conaway, N. S. Hussain, and E. S. Fiala, “Sex and organ differences in oxidative DNA and RNA damage due to treatment of Sprague-Dawley rats with acetoxime or 2-nitropropane,” Carcinogenesis, vol. 11, no. 9, pp. 1659–1662, 1990. View at Publisher · View at Google Scholar · View at Scopus
  64. E. S. Fiala, G. Nie, R. Sodum, C. C. Conaway, and O. S. Sohn, “2-Nitropropane-induced liver DNA and RNA base modifications: differences between Sprague-Dawley rats and New Zealand white rabbits,” Cancer Letters, vol. 74, no. 1-2, pp. 9–14, 1993. View at Publisher · View at Google Scholar · View at Scopus
  65. T. R. Lewis, C. E. Ulrich, and W. M. Busey, “Subchronic inhalation toxicity of nitromethane and 2-nitropropane,” Journal of Environmental Pathology and Toxicology, vol. 2, no. 5, pp. 233–249, 1979. View at Google Scholar · View at Scopus
  66. H. van Steeg and K. H. Kraemer, “Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer,” Molecular Medicine Today, vol. 5, no. 2, pp. 86–94, 1999. View at Publisher · View at Google Scholar · View at Scopus
  67. J. J. Bernard, C. Cowing-Zitron, T. Nakatsuji et al., “Ultraviolet radiation damages self noncoding RNA and is detected by TLR3,” Nature Medicine, vol. 18, no. 8, pp. 1286–1290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  68. J. B. Mumm and M. Oft, “Cytokine-based transformation of immune surveillance into tumor-promoting inflammation,” Oncogene, vol. 27, no. 45, pp. 5913–5919, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. E. M. Weick and E. A. Miska, “piRNAs: from biogenesis to function,” Development, vol. 141, no. 18, pp. 3458–3471, 2014. View at Publisher · View at Google Scholar
  70. C. Fimognari, M. Lenzi, P. Sestili et al., “Sulforaphane potentiates RNA damage induced by different xenobiotics,” PLoS ONE, vol. 7, no. 4, Article ID e35267, 2012. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Fimognari, P. Sestili, M. Lenzi, G. Cantelli-Forti, and P. Hrelia, “Protective effect of creatine against RNA damage,” Mutation Research, vol. 670, no. 1-2, pp. 59–67, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Fimognari, P. Sestili, M. Lenzi, A. Bucchini, G. Cantelli-Forti, and P. Hrelia, “RNA as a new target for toxic and protective agents,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 648, no. 1-2, pp. 15–22, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. C. Fimognari, F. Berti, G. Cantelli-Forti, and P. Hrelia, “Effect of sulforaphane on micronucleus induction in cultured human lymphocytes by four different mutagens,” Environmental and Molecular Mutagenesis, vol. 46, no. 4, pp. 260–267, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. A. Guidarelli, P. Sestili, and O. Cantoni, “Opposite effects of nitric oxide donors on DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide,” British Journal of Pharmacology, vol. 123, no. 7, pp. 1311–1316, 1998. View at Publisher · View at Google Scholar · View at Scopus
  75. H. Stopper, M. Möller, H. M. Bömmel, and H. H. H. W. Schmidt, “Cytotoxic versus genotoxic effects of nitric oxide (NO),” Toxicology Letters, vol. 106, no. 1, pp. 59–67, 1999. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Costanzi, D. Sidransky, A. Navon, and H. Goldsweig, “Ribonucleases as a novel pro-apoptotic anticancer strategy: review of the preclinical and clinical data for ranpirnase,” Cancer Investigation, vol. 23, no. 7, pp. 643–650, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. W. Dunn, P. Trang, U. Khan, J. Zhu, and F. Liu, “RNase P-mediated inhibition of cytomegalovirus protease expression and viral DNA encapsidation by oligonucleotide external guide sequences,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 26, pp. 14831–14836, 2001. View at Publisher · View at Google Scholar · View at Scopus
  78. N. R. Deleault, R. W. Lucassen, and S. Supattapone, “RNA molecules stimulate prion protein conversion,” Nature, vol. 425, no. 6959, pp. 717–720, 2003. View at Publisher · View at Google Scholar · View at Scopus